Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface

Journal of Pharmaceutical Sciences

Volumn 96, Issue 11, 2007, Pages 3117-3124

  Kosa, Takamitsu ^a   Nishi, Koji ^a   Maruyama, Toru ^a   Sakai, Norifumi ^a   Yonemura, Naoko ^a   Watanabe, Hiroshi ^a   Suenaga, Ayaka ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Albumin; Protein binding; Reverse micelles; Species

Indexed keywords

ALBUMIN; DANSYLSARCOSINE; OXYPHENBUTAZONE; SARCOSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG UPTAKE; HUMAN; NONHUMAN; PROTEIN DENATURATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RAT; REVERSE MICELLE; ULTRAVIOLET RADIATION;

EID: 36849050779     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20887     Document Type: Article

References (31)

1. Peters T, Jr. 1996. All about albumin; biochemistry, genetics, and medical applications. San Diego: Academic Press.
2. Otagiri M. 2005. A molecular functional study on the interactions of drugs with plasma proteins. Drug Metab Pharmacokinet 20:309-323.
3. Kosa T, Maruyama T, Otagiri M. 1997. Species differences of serum albumins: I. Drug binding sites. Pharm Res 14:1607-1612.
4. Ichikawa M, Tsao SC, Lin TH, Miyauchi S, Sawada Y, Iga T, Hanano M, Sugiyama Y. 1992. 'Albumin-mediated transport phenomenon' observed for ligands with high membrane permeability. Effect of the unstirred water layer in the Disse's space of rat liver. J Hepatol 16:38-49.
5. Tsao SC, Sugiyama Y, Shinmura K, Sawada Y, Nagase S, Iga T, Hanano M. 1988. Protein-mediated hepatic uptake of rose bengal in analbuminemic mutant rats (NAR). Albumin is not indispensable to the protein-mediated transport of rose bengal. Drug Metab Dispos 16:482-489.
6. Forker EL, Luxon BA, Snell M, Shurmantine WO. 1982. Effect of albumin binding on the hepatic transport of rose bengal: Surface-mediated dissociation of limited capacity. J Pharmacol Exp Ther 223:342-347.
7. Cai ZS, Burczynski FJ, Luxon BA, Forker EL. 1992. On the design and interpretation of experiments to elucidate albumin-dependent hepatic uptake. Am J Physiol 262:G1127-G1137.
8. Horie T, Mizuma T, Kasai S, Awazu S. 1988. Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. Am J Physiol 254:G465-G470.
9. Schnitzer JE, Oh P. 1994. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem 269:6072-6082.
10. Tiruppathi C, Finnegan A, Malik AB. 1996. Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cells. Proc Natl Acad Sci USA 93:250-254.
11. Wolf G, Schroeder R, Ziyadeh FN, Stahl RA. 2004. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Kidney Int 66:1849-1858.
12. Ashman N, Harwood SM, Kieswich J, Allen DA, Roberts NB, Mendes-Ribeiro AC, Yaqoob MM. 2005. Albumin stimulates cell growth, L-arginine transport, and metabolism to polyamines in human proximal tubular cells. Kidney Int 67:1878-1889.
13. Reed RG, Burrington CM. 1989. The albumin receptor effect may be due to a surface-induced conformational change in albumin. J Biol Chem 264:9867-9872.
14. Luisi PL, Steinmann-Hofmann B. 1987. Activity and conformation of enzymes in reverse micellar solutions. Methods Enzymol 136:188-216.
15. Halskau O, Froystein NA, Muga A, Martinez A. 2002. The membrane-bound conformation of alpha-lactalbumin studied by NMR-monitored 1H exchange. J Mol Biol 321:99-110.
16. Agasoster AV, Halskau O, Fuglebakk E, Froystein NA, Muga A, Holmsen H, Martinez A. 2003. The interaction of peripheral proteins and membranes studied with alpha-lactalbumin and phospholipid bilayers of various compositions. J Biol Chem 278:21790-21797.
17. Desfosses B, Cittanova N, Urbach W, Waks M. 1991. Ligand binding at membrane mimetic interfaces. Human serum albumin in reverse micelles. Eur J Biochem 199:79-87.
18. Desfosses B, Nicot C, Waks M. 1992. A drug release-facilitating mechanism for human serum albumin in reverse micelles: Requirement of a structural switch. Biochem Int 26:257-264.
19. Chen RF. 1967. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 242:173-181.
20. Nishi K, Sakai N, Komine Y, Maruyama T, Halsall HB, Otagiri M. 2002. Structural and drug-binding properties of alpha1-acid glycoprotein in reverse micelles. Biochim Biophys Acta 1601:185-191.
21. Attallah NA, Lata GF. 1968. Steroid-protein interactions studies by fluorescence quenching. Biochim Biophys Acta 168:321-333.
22. Kosa T, Maruyama T, Otagiri M. 1998. Species differences of serum albumins: II. Chemical and thermal stability. Pharm Res 15:449-454.
23. Abd Elbary A, Vallner JJ, Whitworth CW1982. Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin. J Pharm Sci 71:241-244.
24. Gu C, Nikolic D, Lai J, Xu X, van Breemen RB. 1999. Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry. Comb Chem High Throughput Screen 2:353-359.
25. Kosa T, Maruyama T, Sakai N, Yonemura N, Yahara S, Otagiri M. 1998. Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions. Pharm Res 15:592-598.
26. Nishi K, Maruyama T, Halsall HB, Handa T, Otagiri M. 2004. Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release. Biochemistry 43:10513-10519.
27. Banuelos S, Muga A. 1995. Binding of molten globule-like conformations to lipid bilayers. Structure of native and partially folded alpha-lactalbumin bound to model membranes. J Biol Chem 270:29910-29915.
28. Nishi K, Komine Y, Sakai N, Maruyama T, Otagiri M. 2005. Cooperative effect of hydrophobic and electrostatic forces on alcohol-induced alpha-helix formation of alpha1-acid glycoprotein. FEBS Lett 579:3596-3600.
29. Anraku M, Kragh-Hansen U, Kawai K, Maruyama T, Yamasaki Y, Takakura Y, Otagiri M. 2003. Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo. Pharm Res 20:684-692.
30. Anraku M, Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M. 2001. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res 18:632-639.
31. Nakajou K, Watanabe H, Kragh-Hansen U, Maruyama T, Otagiri M. 2003. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim Biophys Acta 1623:88-97.